GlycoPath Appoints Kathy Phlegar as CEO

/PRNewswire/ -- GlycoPath Inc., developer of advanced bioanalytical assays based on its proprietary GlycoTyper™ immunoaffinity technology, has appointed Kathy...

Related Keywords

Kathy Phlegar ,Richard Drake ,Danielle Scott ,Zucker Institute For Innovation Commercialization ,University Of South Carolina ,Glycopath Inc ,Medical University ,South Carolina ,Glycopath ,Nc ,